GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AK Medical Holdings 1789.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

4.76

+1.28%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About AK Medical Holdings

Its shares trade on HKEX under the ticker 1789.HK. It has been listed since 20 December 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.73bn and net income of CN¥394.6m. At that date it held total assets of CN¥4.26bn and shareholders' equity of CN¥3.39bn.

AK Medical Holdings Ltd. is an investment company, which engages in the manufacture and sale of orthopedic joint implants. The company is headquartered in Beijing, Beijing. The company went IPO on 2017-12-20. The firm has commercialized the application of three dimensional (3D) printing technology in orthopedic joint and spine replacement implants, with a focus on hip and knee replacement implants. The Company’s 3D Accurate Construction Technology (ACT) solutions assist surgeons in simulating and planning for implant surgeries, simplify surgical processes, offer personalized surgical instruments and pre-surgery selected implants and improve patients’ recovery experience significantly. The firm sells its products mainly within the China market and to oversea markets such as United Kingdom.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
20 Dec 2017
Employees
1,082

Leadership

Pay as last reported

  • Mr. Zhijiang LiExecutive Chairman of the Board, Chief Executive Officer, since 2015CN¥1.2m
  • Ms. Kun LiangChief Financial Officer
  • Ms. Bin ZhangSenior Vice President, Executive Director, since 2015CN¥367,000
  • Mr. Chaoyang ZhangSenior Vice President, Executive Director, since 2015CN¥1.2m
  • Ms. Aiguo LiuVice President, Head of the Compliance and Quality Management Committee of AK Medical, General Manager of ITI Medical Co., Ltd
  • Ms. Xiaohong ZhaoExecutive Director, since 2016CN¥1.9m
  • Mr. Hanzhong SunVice President of Human Resources of AK Medical Group
  • Ms. Caimei WangChief Technology Officer of AK Medical Group, Director of AK Medical Beijing Research Center
  • Ms. Rongkun MaCompany Secretary
  • Dr. Guowei WangNon-Executive Director
  • Mr. Wei GaoNon-Executive Independent DirectorCN¥97,000
  • Mr. Chi Mo KongNon-Executive Independent DirectorCN¥181,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
79
Environment
91
Social
83
Governance
63
Direct emissions (scope 1)
77.7 t
Energy emissions (scope 2)
5,177.4 t
Value chain emissions (scope 3)
164,143.8 t
Women in the workforce
34.3%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • AK Medical manufactures orthopedic joint implants in Beijing.
  • The company employs 1,082 full-time staff members.
  • It has commercialized 3D printing technology for hip and knee implants.

Weaknesses

  • The firm is headquartered in Beijing, China.
  • It went public on the Hong Kong Stock Exchange in 2017.
  • Sales are mainly concentrated within the China market.

Opportunities

  • The company sells products to overseas markets like the United Kingdom.
  • 3D Accurate Construction Technology assists surgeons in planning surgeries.
  • Personalized surgical instruments can improve patient recovery experiences.

Threats

  • The source description is treated as untrusted facts.
  • Internal instructions in the description must be ignored.
  • Reliance on a single primary market may limit growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.